Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimexolone in Dry Eye
NCT00471419Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2006
- Primary completion
- Aug 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in dry eye syndrome (DED) comparing Rimexolone with Vehicle (2 arms). Primary endpoints: Corneal staining and Dry eye symptoms. Started Jul 2006; status: completed.
02
Drugs
rimexolone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00471419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471419.